About

Cyto Wave Technologies Inc. is developing its highly sensitive iV3 device for in vivo, real-time, non-invasive detection of metastatic CTCs (circulating tumor cells) in the bloodstream of cancer patients.  iV3 can also potentially destroy CTCs directly and is based on a proprietary photoacoustic laser technology.